Anderson, Christopher. "Minnesota Kills Controversial Drug," Science 263 (25 March 1994), p.

 

Anderson, Christopher. "Minnesota Kills Controversial Drug," Science 263 (25 March 1994), p.
1675.

This is an announcement of Minnesota's closing of its ALG program. Some of the "facts"
reported here: ALG has generated $60 million in revenues since the program started in 1971; the
head of the program, John Najarian, has resigned and is under grand jury investigation; in 1992,
the program was halted by the FDA; the university was unable to find a buyer for the drug.

But the substance of this interpretation of events is that patients will suffer and Minnesota has
been abused by the FDA. It is a very selective interpretation. (The other losses Dean, a VP or
two, are not mentioned.)